Protalix Biotherapeutics' Series C Round

Protalix Biotherapeutics raised a round of funding on August 18, 2005.

Protalix Biotherapeutics is a biopharmaceutical company that is focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary ProCe…

Articles about Protalix Biotherapeutics' Series C Round: